Related Experiment Video
Updated: Aug 14, 2025
07:24
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
New Treatments for Myelofibrosis
Douglas Tremblay1, Ruben Mesa2,3
1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Current Treatment Options in Oncology
|January 14, 2023
Summary
New myelofibrosis (MF) therapies targeting pathways beyond JAK inhibitors are emerging. These agents offer hope for patients resistant to current treatments and may shift MF treatment paradigms toward combination therapies.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Current Janus kinase (JAK) inhibitor therapies for myelofibrosis (MF) improve symptoms but do not halt leukemic progression.
- Therapeutic resistance and intolerance limit the effectiveness of existing MF treatments, creating unmet needs.
Purpose of the Study:
- To review emerging therapeutic agents for myelofibrosis targeting pathways beyond the JAK-STAT pathway.
- To discuss the potential of these novel agents, often used in combination, to address treatment resistance and improve outcomes in MF.
Main Methods:
- Review of current clinical development landscape for myelofibrosis therapies.
- Analysis of novel agents targeting pathways including BET, BCL-2/BCL-xL, PI3k, and others.
Main Results:
- Numerous novel agents targeting diverse pathways are in clinical development for MF.
- These agents are being investigated as monotherapy or in combination with JAK inhibitors.
Conclusions:
- Next-generation therapies targeting multiple aspects of MF pathophysiology are poised to change treatment paradigms.
- Combination strategies hold promise for overcoming resistance and improving patient outcomes in myelofibrosis.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:22Bone Marrow Sampling and Transplants
386
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
386
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
215
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
215
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K